Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling

Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling

Assistant Professor    #5402    cch1120@mail.npust.edu.tw
Year2022
Author陳肇閎, Yu-Jen Lin, 鄭力廷, Chien-Hung Lin, 柯冠銘*
Author count5
Created date2022-05-16
Author order第一作者
Corresponding author
Publication year2022
Publication month5
Journal nameVaccines
Publication area瑞士聯邦
Volume10
Issue5
Start page715
Publication type
Review system
LanguageTraditional Chinese